Clinical Trial

Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders

Study acronym: Transcranial
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of transcranial direct current stimulation (tDCS) in reducing core symptoms of different psychiatric disorders using validated clinical scales. * To assess response and remission rates. * To evaluate the durability of treatment effects over follow-up. * To examine effects on cognition, daily functioning, and quality of life. * To monitor tolerability and adverse events.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-01.
Trial Details
NCT Number NCT07452835
Lead Sponsor Menoufia University
Conditions Major Depressive Disorder (MDD), SCHIZOPHRENIA 1 (Disorder), Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Insomnia
Enrollment 320 participants
Start Date 2024-01-01
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-06